The HGF/c-MET signaling pathway then modulates the breast tumor microenvironment and drives malignant transformation by inducing c-MET dimerization and phosphorylation, which activates downstream pathways such as MAPK and PI3K21. The gene discussed is MET; the disease is breast neoplasm.